Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Integrated chemo-radiotherapy in elderly patients with stage III NSCLC (Phase II)
2007-003098-21Phase 2Active
- Sponsor
- AOU Città della Salute e della Scienza di Torino
- Start
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cisplatin and vinorelbine in non-small cell lung cancer (NSCLC), sponsored by AOU Città della Salute e della Scienza di Torino. Primary endpoints: Activity of integrated chemo-radiotherapy schedule and Duration of response. Started Jul 2007; status: active.
02
Drugs
cisplatinvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on 2007-003098-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003098-21.